M33.90, Dermatopolymyositis, unspecified, organ involvement unspecifiedICD-10-CM
No Prior Auth Required
Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)
A57554, Billing and Coding: Immune Globulins
J5
A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5
WPS-J5-L34771, Immune Globulins
J5
A57668, Billing and Coding: Nerve Conduction Studies and Electromyography
J6
A59101, Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J6
NGS-J6-L39297, Off-label Use of Rituximab and Rituximab Biosimilars
J6
NGS-J6-L35098, Nerve Conduction Studies and Electromyography
J6
NGS-J6-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)
J6
A59105, Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)
J6
A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J6
WPS-J8-L34771, Immune Globulins
J8
A57657, Billing and Coding: Sedimentation Rate, Erythrocyte
J9
FIRST_COAST-L33771, Vitamin D; 25 hydroxy, includes fraction(s), if performed
J9
FIRST_COAST-L34021, Sedimentation Rate, Erythrocyte
J9
A59764, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J9
A56841, Billing and Coding: Vitamin D; 25 hydroxy, includes fraction(s), if performed
J9
NOVITAS-JH-L34914, Assays for Vitamins and Metabolic Function
JH
NGS-JK-L35098, Nerve Conduction Studies and Electromyography
JK
NGS-JK-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)
JK
NGS-JK-L39297, Off-label Use of Rituximab and Rituximab Biosimilars
JK
Ask Backwork about documentation requirements, denial risks, or coverage in your state.